Wolfram Eisenreich;Karl G. Wagner;Thomas Friedl;Florian Sommer;Nantharat Pearnchob
发明人:
Wolfram Eisenreich,Thomas Friedl,Florian Sommer,Nantharat Pearnchob,Karl G. Wagner
申请号：
US11837959
公开号：
US08658207B2
申请日:
2007.08.13
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention provides pharmaceutical release systems comprising an therapeutically effective amount of flibanserin and at least one pharmaceutically acceptable excipient, characterized in that said pharmaceutical release systems exhibit a pharmacokinetic profile that is characterized by an average maximum flibanserin plasma concentration Cmax lower than 300 ng/mL, preferably lower than 200 ng/mL after administration of a single dose to healthy volunteers in fasted state or directly after a meal.
